Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort-Reference-Cited by-同舟云学术

Retrospectively validating the results of the ACOSOG Z0011 trial in a large Asian Z0011-eligible cohort

Published:2019-02-04 Issue:1 Volume:175 Page:203-215
ISSN:0167-6806
Container-title:Breast Cancer Research and Treatment
language:en
Short-container-title:Breast Cancer Res Treat

Author:

Jung Jiwoong,Han Wonshik,Lee Eun Sook,Jung So-Youn,Han Jai Hong,Noh Dong-Young,Kim Yumi,Choi Hee Jun,Lee Jeong Eon,Nam Seok Jin,Lee Jong Won,Kim Hee Jeong,Um Eunhae,Kim Joo Heung,Park Seho,Cho Young Up

Funder

Ministry of Health and Welfare

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://link.springer.com/article/10.1007/s10549-019-05157-4/fulltext.html

Reference30 articles.

1. Giuliano AE, Hunt KK, Ballman KV, Beitsch PD, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, McCall LM, Morrow M (2011) Axillary dissection vs no axillary dissection in women with invasive breast cancer and sentinel node metastasis: a randomized clinical trial. JAMA 305(6):569–575. https://doi.org/10.1001/jama.2011.90

2. Giuliano AE, Ballman KV, McCall L, Beitsch PD, Brennan MB, Kelemen PR, Ollila DW, Hansen NM, Whitworth PW, Blumencranz PW, Leitch AM, Saha S, Hunt KK, Morrow M (2017) Effect of axillary dissection vs no axillary dissection on 10-year overall survival among women with invasive breast cancer and sentinel node metastasis: the ACOSOG Z0011 (alliance) randomized clinical trial. JAMA 318(10):918–926. https://doi.org/10.1001/jama.2017.11470

3. Giuliano AE, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Hunt KK, Morrow M, Ballman K (2010) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: the American College of Surgeons Oncology Group Z0011 randomized trial. Ann Surg 252(3):426–432. https://doi.org/10.1097/SLA.0b013e3181f08f32 discussion 432–423.

4. Giuliano AE, Ballman K, McCall L, Beitsch P, Whitworth PW, Blumencranz P, Leitch AM, Saha S, Morrow M, Hunt KK (2016) Locoregional recurrence after sentinel lymph node dissection with or without axillary dissection in patients with sentinel lymph node metastases: long-term follow-up from the American College of Surgeons Oncology Group (alliance) ACOSOG Z0011 randomized trial. Ann Surg 264(3):413–420. https://doi.org/10.1097/SLA.0000000000001863

5. Poodt IGM, Spronk PER, Vugts G, van Dalen T, Peeters M, Rots ML, Kuijer A, Nieuwenhuijzen GAP, Schipper RJ (2017) Trends on axillary surgery in nondistant metastatic breast cancer patients treated between 2011 and 2015: a dutch population-based study in the ACOSOG-Z0011 and AMAROS Era. Ann Surg. https://doi.org/10.1097/SLA.0000000000002440

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparison of clinical characteristics between ACOSOG Z0011–eligible cohort and sentinel lymph node–positive breast cancer patients in Hong Kong;Hong Kong Medical Journal;2024-03-25

2. An exploratory study of whether axillary lymph node dissection can be avoided in breast cancer patients with positive lymph nodes;Translational Cancer Research;2024-02

3. Efficacy and safety comparison between axillary lymph node dissection with no axillary surgery in patients with sentinel node-positive breast cancer: a systematic review and meta-analysis;BMC Surgery;2023-07-26

4. Patterns of management of positive sentinel lymph nodes in breast cancer patients after the American College of Surgeons Oncology Group Z0011 trial: a retrospective cohort;2023-06-13

5. Axilla lymph node dissection can be safely omitted in patients with 1–2 positive sentinel nodes receiving mastectomy: a large multi-institutional study and a systemic meta-analysis;Breast Cancer Research and Treatment;2022-09-08